Specifically, the secondary transplantation experiment revealed that the loss of OVOL2 in mouse breast tumor cells resulted in enhanced and more stable tumor‐initiating capacity, further highlighting the crucial role of OVOL2 in regulating CSC properties in vivo. This evidence concerns the gene OVOL2 and breast neoplasm.